Annexin A2: its molecular regulation and cellular expression in cancer development

Chi-Yun Wang1, Chiou-Feng Lin1

  • 1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, 1 University Road, Tainan 701, Taiwan.

Disease Markers
|March 5, 2014
PubMed

Insights

Annexin A2 (ANXA2) plays a key role in cancer progression, influencing its development, detection, and drug resistance. Targeting ANXA2 presents a promising therapeutic strategy for cancer management.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Annexin A2 (ANXA2) is a protein involved in various biological processes.
  • Its structure, posttranslational modifications, and proteolytic cleavage critically regulate its function and cellular localization.
  • ANXA2 expression is notably altered in various cancer types.

Purpose of the Study:

  • To review the multifaceted roles of Annexin A2 (ANXA2) in cancer development.
  • To explore the potential of ANXA2 as a diagnostic marker and therapeutic target in oncology.

Main Methods:

  • This review synthesizes existing research on Annexin A2.
  • It analyzes studies focusing on ANXA2's structure-function relationships, posttranslational modifications, and expression patterns in cancer.
  • Literature was examined for ANXA2's involvement in cancer progression, diagnosis, and therapeutic resistance.

Main Results:

  • ANXA2's expression levels differ across various cancers, suggesting its potential utility in cancer detection and diagnosis.
  • ANXA2 is implicated in key cancer processes, including progression and the development of drug resistance.
  • Its activity in cancer development highlights its significance.

Conclusions:

  • Annexin A2 (ANXA2) is a significant factor in cancer development and progression.
  • ANXA2 holds potential as a biomarker for cancer detection, diagnosis, and monitoring.
  • Targeting ANXA2 is a feasible and promising therapeutic strategy for improved cancer management.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K